Yuhan Corporation, Stock Price +0.15% at This Time... 94,664 Shares Net Bought by Individuals in the Last 5 Days
Yuhan Corporation is trading at 67,800 KRW as of 9:30 AM on the 6th, up 0.15% from the previous day. The trading volume is 909,030 shares, which is about 7.38% of the previous day's volume. Yuhan Corporation is known as one of the leading domestic pharmaceutical companies specializing in prescription drugs.
On August 3rd, researchers Mi-hwa Seo and Hye-in Lee from Yuanta Securities projected a 3.2% growth in sales and assumed the possibility of receiving additional milestone payments (16 billion KRW milestone related to Janssen’s Phase 3 clinical trial initiation). They noted that clinical trials for new drug pipelines such as Lazertinib and NASH treatments are progressing smoothly, increasing the likelihood of milestone receipts. They set Yuhan Corporation’s target price at 64,000 KRW.
Over the past five days, individual investors have net purchased 94,664 shares of Yuhan Corporation, while foreign and institutional investors have net sold 54,424 shares and 88,574 shares, respectively.

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
Cerebras Soars 70% on IPO Debut: Is Nvidia's Reign Ending as a New AI Semiconductor Power Emerges?
- After Surpassing 8,000 Points, Is Profit-Taking Underway?... Why Is the KOSPI Plunging?
- "Gave in to the Momentary Temptation": Japanese Police Official Dismissed After Stealing 100 Million Won Next to Body
- "Mom, Isn't It Comfortable Living With Me?"... 'Unexpected Result' Shows Increased Drinking Out of Frustration
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.